SCICLONE PHARMA: UPDATE ON QUALIFICATIONS OF JOINT COMPANY SECRETARY AND RESIGNATION OF JOINT COMPANY SECRETARY
SCICLONE PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024
SCICLONE PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024
SCICLONE PHARMA: VOLUNTARY ANNOUNCEMENT - SciClone Announces Phase III Clinical Trial of Vaborem Completed Subject Enrollment in China
SCICLONE PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023
SCICLONE PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2023
SCICLONE PHARMA: VOLUNTARY ANNOUNCEMENT - SCICLONE AND MENARINI ESTABLISH LICENSE AND COLLABORATION AGREEMENT FOR ORSERDU IN CHINA
SCICLONE PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2023
SCICLONE PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2023
SCICLONE PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2023
SCICLONE PHARMA: Next Day Disclosure Return
SCICLONE PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2023
SCICLONE PHARMA: Next Day Disclosure Return
SCICLONE PHARMA: Next Day Disclosure Return
SCICLONE PHARMA: Next Day Disclosure Return
SCICLONE PHARMA: Next Day Disclosure Return
SCICLONE PHARMA: Next Day Disclosure Return
SCICLONE PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2023
SCICLONE PHARMA: VOLUNTARY ANNOUNCEMENT - SciClone Announces First Subject Dosed in Phase III Clinical Trial of Vaborem in China
SCICLONE PHARMA: VOLUNTARY ANNOUNCEMENT - COMMERCIAL LAUNCH OF DANYELZA (NAXITAMAB) IN CHINA
No Data